- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 249-263 of
466 results
1160 Exhibit: FEMARA Label
Document
IPR2019-00170, No. 1160-218 Exhibit - FEMARA Label (P.T.A.B. Dec. 12, 2019)
|
|
Cite Document
1121 Exhibit: Mori et al, 17 Intl J Oncology 33 2000
Document
IPR2019-00170, No. 1121-179 Exhibit - Mori et al, 17 Intl J Oncology 33 2000 (P.T.A.B. Dec. 12, 2019)
|
|
Cite Document
2070 Exhibit: Declaration of Corrin Drakulich
Document
IPR2019-00170, No. 2070-173 Exhibit - Declaration of Corrin Drakulich (P.T.A.B. Oct. 4, 2019)
|
|
Cite Document
2037 Exhibit: Kari et al, ¿¿¿Targeting the Epidermal Growth Factor in Cancer,¿¿¿ Canc...
Document
IPR2019-00170, No. 2037-140 Exhibit - Kari et al, ¿¿¿Targeting the Epidermal Growth Factor in Cancer,¿¿¿ Cancer Research, Vol 63, January 1, 2003, pp 1 5 (P.T.A.B. Sep. 19, 2019)
|
|
Cite Document
2051 Exhibit: Mace L Rothenberg, ¿¿¿Irinotecan CPT 11 ¿¿¿Recent Developments an...
Document
IPR2019-00170, No. 2051-154 Exhibit - Mace L Rothenberg, ¿¿¿Irinotecan CPT 11 ¿¿¿Recent Developments and Future Directions¿¿¿Colorectal Cancer and Beyond,¿¿¿ The Oncologist, pp 66 80 (P.T...
|
|
Cite Document
2028 Exhibit: Gleevec¿¿ FDA 2001 Approval Letter downloaded from httpswwwacce...
Document
IPR2019-00170, No. 2028-131 Exhibit - Gleevec¿¿ FDA 2001 Approval Letter downloaded from httpswwwaccessdatafdagovscriptscderdafindexcfmeventoverviewprocessApplNo021335 on Augu...
|
|
Cite Document
2034 Exhibit: Lynch et al, ¿¿¿Activating mutation in the epidermal growth factor rece...
Document
IPR2019-00170, No. 2034-137 Exhibit - Lynch et al, ¿¿¿Activating mutation in the epidermal growth factor receptor underlying responsiveness of non small cell lung cancer to gefitinib,¿¿¿ NEJM, Vo...
|
|
Cite Document
2049 Exhibit: Rodriguez Viciana et al, ¿¿¿Cancer Targets in the Ras Pathway,¿¿¿ Cold...
Document
IPR2019-00170, No. 2049-152 Exhibit - Rodriguez Viciana et al, ¿¿¿Cancer Targets in the Ras Pathway,¿¿¿ Cold Spring Harbor Laboratory Press 2005, pp 461 467 (P.T.A.B. Sep. 19, 2019)
|
|
Cite Document
2024 Exhibit: National Comprehensive Cancer Network, ¿¿¿Colon Cancer Version 12...
Document
IPR2019-00170, No. 2024-127 Exhibit - National Comprehensive Cancer Network, ¿¿¿Colon Cancer Version 12017 Clinical Practice Guidelines in Oncology¿¿¿, Journal of the National Comprehens...
|
|
Cite Document
2048 Exhibit: Kanaya et al, ¿¿¿Frequent Hypermethylation of MLH1 Promoter in Norm...
Document
IPR2019-00170, No. 2048-151 Exhibit - Kanaya et al, ¿¿¿Frequent Hypermethylation of MLH1 Promoter in Normal Endometrium of Patients with Endometrial Cancers,¿¿¿ Oncogene pp 2352 2360 ...
|
|
Cite Document
1100 Exhibit: Mark Abramovitz Brian Leyland Jones, A Systems Approach toClinica...
Document
IPR2019-00170, No. 1100-101 Exhibit - Mark Abramovitz Brian Leyland Jones, A Systems Approach toClinical Oncology Focus on Breast Cancer, 4 Proteome Sci 2006 (P.T.A.B. Jun. 24, 2019)
|
|
Cite Document
1107 Exhibit: Affymetrix, Inc v Illumina, Inc, No 104 cv 00901 JJF, DI 209 D Del Feb...
Document
IPR2019-00170, No. 1107-108 Exhibit - Affymetrix, Inc v Illumina, Inc, No 104 cv 00901 JJF, DI 209 D Del Feb 9, 2006 (P.T.A.B. Jun. 24, 2019)
|
|
Cite Document
1148 Exhibit: Clinical Trial Ref No NCT00065533
Document
IPR2019-00170, No. 1148-206 Exhibit - Clinical Trial Ref No NCT00065533 (P.T.A.B. Dec. 12, 2019)
|
|
Cite Document
1131 Exhibit: LinkedIn profile for Dr Joanne Yeakley
Document
IPR2019-00170, No. 1131-189 Exhibit - LinkedIn profile for Dr Joanne Yeakley (P.T.A.B. Dec. 12, 2019)
|
|
Cite Document
1150 Exhibit: Clinical Trial Ref No NCT00113373
Document
IPR2019-00170, No. 1150-208 Exhibit - Clinical Trial Ref No NCT00113373 (P.T.A.B. Dec. 12, 2019)
|
|
Cite Document
